checkAd

     629  0 Kommentare MagForce AG presents NanoTherm(TM) therapy for the treatment of brain tumors at ECCO2017 from January 27-30, 2017 in Amsterdam









    DGAP-Media / 23.01.2017 / 08:30



    MagForce AG presents NanoTherm(TM) therapy for the treatment of brain tumors at ECCO2017 from January 27-30, 2017 in Amsterdam



    The Company will also attend ESSO 37 One-Day Educational Conference held in conjunction with ECCO2017



    Berlin, Germany and Nevada, USA, January 23rd, 2017 - MagForce AG (Frankfurt, Entry Standard, XETRA: MF6, ISIN: DE000A0HGQF5), a leading medical device company in the field of nanomedicine focused on oncology, announced today its attendance at ECCO2017, the European Cancer Congress held by the European CanCer Organisation (ECCO) from January 27-30, 2017, in Amsterdam, The Netherlands. The ECCO2017 Conference is an important meeting event for international key opinion leaders attending clinical symposia and sessions on multidisclipinary tumor boards focussing, amongst other indications, on the central nervous system.



    This multidisciplinary oncology congress promotes close interaction between neurosurgeons, surgical oncologists and fellow oncology professionals.



    At ECCO2017 congress, where new treatments of value to patients will be discussed and presented, MagForce will be represented by a booth (No. IH17) and will be available for questions regarding its NanoTherm(TM) therapy for the treatment of glioblastoma and other brain tumors.



    About ECCO2017



    ECCO2017 is a unique, clinically oriented, multidisciplinary annual congress with a strong educational focus for practicing oncologists and other health care professionals who need to be updated on the relevant clinical information which will impact on their daily practice. ECCO2017 is organized by European CanCer Organisation (ECCO) which, through its 25 Member Societies - representing over 80.000 professionals - is the only multidisciplinary organisation that connects and responds to all stakeholders in oncology Europe-wide.



    The programme is built around the four key pillars multidisciplinarity, outcome research, health economics of cancer care and organisation of cancer care delivery.



    ESSO 37 at ECCO2017



    The European Society of Surgical Oncology invites all surgical oncologists and fellow oncology professionals from all disciplines to the ESSO society day at ECCO2017 on January 27th 2017.

    Seite 1 von 3


    EQS Group AG
    0 Follower
    Autor folgen

    Verfasst von EQS Group AG
    MagForce AG presents NanoTherm(TM) therapy for the treatment of brain tumors at ECCO2017 from January 27-30, 2017 in Amsterdam DGAP-Media / 23.01.2017 / 08:30 MagForce AG presents NanoTherm(TM) therapy for the treatment of brain tumors at ECCO2017 from January 27-30, 2017 in Amsterdam The Company will also attend ESSO 37 One-Day Educational Conference held in conjunction …